Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
High-fat diet–induced vagal afferent dysfunction via upregulation of 2-pore domain potassium TRESK channel
Gintautas Grabauskas, … , Jun Gao, Chung Owyang
Gintautas Grabauskas, … , Jun Gao, Chung Owyang
Published September 5, 2019
Citation Information: JCI Insight. 2019;4(17):e130402. https://doi.org/10.1172/jci.insight.130402.
View: Text | PDF | Corrigendum | Retraction
Research Article Endocrinology Gastroenterology

High-fat diet–induced vagal afferent dysfunction via upregulation of 2-pore domain potassium TRESK channel

  • Text
  • PDF
Abstract

Research shows that rats and humans on a high-fat diet (HFD) are less sensitive to satiety signals known to act via vagal afferent pathways. We hypothesize that HFD causes an upregulation of 2-pore domain potassium channels, resulting in hyperpolarization of nodose ganglia (NG) and decreased vagal response to satiety signals, which contribute to hyperphagia. We show that a 2-week HFD caused an upregulation of 2-pore domain TWIK-related spinal cord K+ (TRESK) and TWIK-related acid-sensitive K+ 1 (TASK1) channels by 330% ± 50% and 60% ± 20%, respectively, in NG. Patch-clamp studies of isolated NG neurons demonstrated a decrease in excitability. In vivo single-unit NG recordings showed that a 2-week HFD led to a 55% reduction in firing frequency in response to CCK-8 or leptin stimulation. NG electroporation with TRESK siRNA restored NG responsiveness to CCK-8 and leptin. Rats fed a 2-week HFD consumed ~40% more calories compared with controls. Silencing NG TRESK but not TASK1 channel expression in HFD-fed rats restored normal calorie consumption. In conclusion, HFD caused upregulation of TRESK channels, resulting in NG hyperpolarization and decreased vagal responsiveness to satiety signals. This finding provides a pharmacological target to prevent or treat HFD-induced hyperphagia.

Authors

Gintautas Grabauskas, Xiaoyin Wu, ShiYi Zhou, JiYao Li, Jun Gao, Chung Owyang

×

Figure 5

Effects of TRESK and TASK1 siRNA transfection on basic membrane properties of vagal sensory neurons from HFD-fed rats.

Options: View larger image (or click on image) Download as PowerPoint
Effects of TRESK and TASK1 siRNA transfection on basic membrane properti...
(A) Representative current-clamp recordings from vagal sensory neurons obtained from LFD or HFD + control siRNA and HFD + TRESK siRNA or HFD + TASK1 siRNA groups of rats. Membrane voltage responses were generated in response to –100 pA, 0 pA, and double rheobase amplitude current pulse of 500-ms duration. (B) Summary histograms illustrate significantly reduced neuronal input resistance (Rin), increased amplitude of the rheobase (pA), and reduced number of APs discharged by double amplitude current pulse in nodose neurons from 2-week HFD + control siRNA (n = 13) rats compared with those given an LFD + control siRNA (n = 14). These data show that pretreatment of vagal sensory ganglia with TRESK siRNA (n = 12) but not TASK1 siRNA (n = 11) reversed the effect of HFD on the excitability of sensory neurons. Data are represented as mean ± SEM. #P < 0.05 vs. LFD + control siRNA; +P < 0.05 vs. HFD + control siRNA; *P < 0.05 vs. HFD + TRESK siRNA, 1-way ANOVA with Bonferroni’s test. AP, action potential.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts